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doi:10.1016/j.ejvs.2010.10.016Abstract Objective: Cerebral hyperperfusion syndrome is a preventable cause of stroke
after carotid endarterectomy (CEA). It manifests as headache, seizures, hemiparesis or coma
due to raised intracranial pressure or intracerebral haemorrhage (ICH). There is currently no
consensus on whether to control blood pressure, blood pressure thresholds associated with
cerebral hyperperfusion syndrome, choice of anti-hypertensive agent(s) or duration of treat-
ment.
Method: A systematic review of the PubMed database (1963e2010) was performed using
appropriate search terms according to Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines.
Results: A total of 36 studies were identified as fitting a priori inclusion criteria. Following
CEA, the incidence of severe hypertension was 19%, that of cerebral hyperperfusion 1% and
ICH 0.5%. The postoperative mean systolic blood pressure of patients, who went on to develop
cerebral hyperperfusion syndrome, was 164 mmHg (95% confidence interval (CI)
150e178 mmHg) and the cumulative incidence of cases rose appreciably above a postoperative
systolic blood pressure of 150 mmHg. The mean systolic blood pressure of cerebral hyperper-
fusion cases was 189 mmHg (95% CI 183e196 mmHg) at presentation. The incidence of cerebral
hyperperfusion in the first week was 92% with a median time to presentation of 5 days
(interquartile range (IQR) 3e6 days). 36% of patients presented with seizures 31% with hemi-
paresis and 33% with both. The proportion of patients with severe hypertension was signifi-
cantly higher in cases than in post-CEA controls (p < 0.0001, Odds ratio 19 (95% CI 9e41)).
Three large case-control studies identify postoperative hypertension as a risk factor for ICH.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’.
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230 S. Bouri et al.Conclusion: There is currently level-3 evidence for the prevention of ICH through control of
postoperative blood pressure. From the available data, we suggest a definition for cerebral hy-
perperfusion syndrome, blood pressure thresholds, duration of monitoring and a postoperative
blood pressure control strategy for validation in a prospective study. The implications of this
are that one in five patients would need intravenous anti-hypertensives and home blood pres-
sure monitoring for 1 week.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Cerebral hyperperfusion syndrome (CHS) is a preventable
cause of perioperative stroke following CEA. As ischaemic
stroke rates improve for CEA, intracerebral haemorrhage
(ICH) is an important concern for the surgical team.1 Brain
imaging is performed to identify cerebral oedema, ICH and
new cerebral infarction. Some centres additionally measure
cerebral blood flow (CBF) with single photon emission
computed tomography (SPECT) or 133Xe computed tomog-
raphy (CT), or middle cerebral artery velocity (MCAv) with
transcranial Doppler (TCD)2 in comparison with preopera-
tive levels to establish if hyperperfusion is present.3e6
Cerebral perfusion pressure is dependent on mean arterial
pressure (minus intracranial pressure and jugular venous
pressure). It is possible to control cerebral perfusion pressure
(normal range 70e100 mmHg)7 by reducing mean arterial
pressureand sittingpatients upright. It hasbeendemonstrated
that severe carotid stenosis causes chronic cerebral hypo-
perfusion8,9 leading to intracerebral vasodilation.10,11 This is
supported by the finding that patients with severe stenosis
have reduced intracerebral vasoreactivity to acetazolamide
compared with normal controls.12e14 Several studies have
shown that reduced preoperative intracerebral vasoreactivity
is a risk factor for hyperperfusion11,12,15,16 and CHS.14 Intra-
cerebral vessels remain dilated for up to 4weeks16,17 following
CEA, and this is the theoretical period of vulnerability for CHS,
as cerebral vascular resistance is lowered. Whether deficient
autoregulation or severe hypertension alone is the culprit is
controversial.6 Both share the easily monitored, easily modi-
fiable risk factor of hypertension. Currently, there is no
consensus on which level of blood pressure (BP) to treat or for
how long. The evidence for the prevention of CHS through the
control of BP is the focus of this article.
Methods
The review was conducted according to Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines in March 2010. The search strategy to find all
articles regarding hypertension and CHS following CEA is
described in Fig. 1. Statistical analysis was performed using
Prism v5.03 (GraphPad Software, California, USA). Data was
checked for normality, two-tailed tests used and statistical
significance taken as p < 0.05.
Inclusion and exclusion criteria
Publications between 1963 and 2010, regarding humans in
the English language were included. We selected studies
with more than 500 patients when assessing the evidence
that BP control could prevent CHS because the incidence ofthe condition was low. Studies where CHS was diagnosed on
the basis of headache alone were excluded. We considered
subjects undergoing CEA only and not stenting.
Study quality
A total of 20 studies were retrospective and 16 prospective.
Almost all studies included patients with asymptomatic
carotid stenosis (40%) and symptomatic carotid stenosis (60%).
ICH was diagnosed on magnetic resonance (MRI) or computed
tomography (CT) imaging. Patient age rangewas 39e93 years.
There was heterogeneity in the definition of hyperten-
sion. For the purposes of standardisation, we used the clas-
sification of the British Hypertension Society using systolic BP
(sBP) in the following categories: mild (>140 mmHg);
moderate (160e180 mmHg); and severe (>180 mmHg).18
Results
Clinical presentation
CHS presented with seizures in 36% (15/42), hemiparesis in
31% (13/42) or both in 33% (14/42) of patients. ICH presented
with seizures in 31% (11/36), hemiparesis in 25% (9/36), both in
31% (11/36) and reduced level of consciousness in 13% (5/36).
Incidence of hypertension in CHS
The incidence of postoperative severe hypertension was
19%,2,19e21 that of CHS 1% and ICH 0.5% (Table 1); 81% of
patients had severe hypertension at the onset of CHS or
ICH. Fig. 2 illustrates that severe hypertension was found in
a significantly greater proportion of CHS patients than post-
CEA controls (p < 0.0001, Odds Ratio 19 (95% CI 9e41)
Fisher’s exact test). The last recorded postoperative sBP of
patients with those who went on to develop CHS was
165 mmHg (95% confidence interval (CI) 151e178 mmHg,
n Z 16). The mean sBP on presentation of CHS was
189 mmHg (95% CI 183e196 mmHg) (nZ 44). Only one case
was normotensive at presentation.
Temporal relationship between hypertension and
symptoms
Fifteen casesmentioned both the postoperative BP and BPat
presentation with CHS (Fig. 3). These cases recorded an sBP
of 140e230 mmHg between 6 h22 and 7 days6 prior to symp-
toms.5,10,23 The shortest documented time fromoperation to
symptoms was 17 h.6 Average time to symptoms was the 5th
postoperative day (interquartile range (IQR) 3e6 days). A
total of 133/145 (92%) of cases of CHS or ICH occurred in the
first week. The latest case was at 28 days.
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Figure 1 PRISMA diagram. Systematic search of the PubMed database in March 2010 yielded 36 studies for quantitative analysis.
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Three large case-control studies identified postoperative BP
as a modifiable risk factor in the development of ICH.
In a North American case-control study of 2747 CEAs,
there were 12 cases of ICH24 compared with 44 post-CEA
controls with >70% stenosis. There was a significant
increase in the incidence of post-CEA hypertension, (odds
ratio (OR) 4.5, p Z 0.04) and in doubling of MCAv (OR 10,
p Z 0.008) in those with ICH compared with controls.
Postoperative hypertension was defined as >160 mmHg sBP
in normotensives or >20 mmHg elevation in hypertensives.
Postoperative anticoagulation was also identified as a risk
factor for ICH in this study.
In a Japanese retrospective case-control series,1 1596
CEAs were analysed retrospectively with multivariate
logistic regression. BP control to the preoperative value was
the only variable that demonstrated risk reduction for ICH
(OR 0.035, p Z 0.016).In a European case series of 688 CEAs,4 the sBP was
controlled to less than 140 mmHg in patients with a post-
operative doubling in MCAv. There was a 0% incidence of
ICH compared with a 2% incidence prior to this.2
Symptomatic hypertension and the development of
ICH
Headache occurred in 20% (138/692) of patients following
CEA without CHS,2,4,25e28 59% (13/22) of patients with CHS
and 84% (32/38) of patients with ICH. The test statistics for
headache with hypertension predicting ICH have been
calculated in a case series of 233 CEAs.2 The positive
predictive value, negative predictive value, sensitivity and
specificity were 24%, 99%, 80% and 94%, respectively.
Treatment of CHS
Rapid restoration of normotension with intravenous anti-
hypertensives can result in resolution of CHS symptoms
Table 1 Incidence of cerebral hyperperfusion syndrome.
Study Year P/R Design CEAs Patients with
CHS (%)
Patients with
ICH (%)
Mortality
of ICH (%)
Criteria for Diagnosis of
CHS or ICH
Beard et al.54 2001 P CS 100 2/100 (2%) 2/100 (2%) Seizures or headache and
oedema or ICH on CT
Bergeron et al.55 1991 P C 114 1/114 (0.8%) ICH on MRI/CT
Bruetman et al.56 1963 R CS 900 6/900 (0.6%) 5/6 (83%)
Coutts et al.29 2003 R CS 129 3/129 (2.3%) 1/129 (0.8%) Ipsilateral neurological deficit with
oedema or ICH (CT/MRI)
Dalman et al.4 1999 P C 688 7/688 (1.1%) TCD MCAv >100% and neurological
deficit or seizures
De borst et al.30 2001 P CS 599 1/599 (0.2%) 1/599 (0.2%)
Ederle et al.57 2010 P RCT 821 5/821 (0.6%)
Fukuda et al.31 2007 P C 70 2/70 (2.8) Headaches, seizures, focal
neurology and CBF on SPECT
GALA under LA58 2008 P RCT 1771 7/1771 (0.4%)
GALA under GA58 2008 P RCT 1752 11/1752 (0.6%)
Henderson et al.24 2001 R CC 2747 12/2747 (0.4%) 7/12 (58%) Hypertension with either severe
headache, seizures or confusion,
or doubling of CBF on 133Xe CT
Hingorani et al.32 2002 R CS 500 2/500 (0.4%) Hypertension, headaches, seizures,
oedema on CT
Jansen et al.2 1994 R CC 233 5/233 (2%) 3/5 (60%) Headache, fits, hypertension
Karapanayiotides et al.23 2005 R CS 388 5/388 (1.3%) 3/388 (1%) Focal deficits and seizures, absence
of ischaemia and presence of oedema
Lepojarvi et al.46 1996 R CS 857 5/857 (0.6%) 3/5 (60%) Headache, convulsion and/or hemiparesis.
CT evidence of ICH
NASCET59 1999 P RCT 1415 3/1415 (0.2%) 1/3 (33%)
Naylor et al.6 2003 P CS 949 6/949 (0.6%) 2/949 (0.2%) 1/2 (50%) Seizures <30days and MCAv >200%
Nielsen et al.8 1995 P C 153 5/153 (3.2%)
Nielsen et al.9 2002 P C 61 2/61 (3.5%) Seizures, hypertension
Ogasawara et al.1 2007 R CS 1596 30/1596 (1.9%) 6/1596 (0.4%) 2/6 (33%) 1) Headache, seizure, reduced consciousness
and/or focal neurology 2) Absence of
ischaemia MRI and 3) Post-operative
increases CBF on SPECT/133Xe CT, or
MCAv >100% by TCD
Ogasawara et al.14 2003 P C 51 2/51 (3.9)
Ogasawara et al.3 2005 P C 60 2/60 (3.3%) 1) Seizure, reduced consciousness, focal
neurologic signs and 2) Hyperperfusion on
SPECT, absence of new ischaemia on CT or MRI
Ouriel et al.60 1999 R CC 1471 11/1471 (0.75%) 4/11 (36%) Neurological deterioration within 30 days and
MRI/CT ICH
Piepgras et al.50 1988 R CS 2632 14/2362 (0.6%) 8/14 (57%)
Pomposelli et al.61 1988 R CS 1500 11/1500 (0.7%) 4/11 (36%)
(continued on next page)
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Figure 2 Incidence of headache and severe hypertension.
The proportion of patients with headache or sBP >180 mmHg is
significantly higher in patients with CHS or ICH compared with
post-CEA controls ()p < 0.0001, zp < 0.0001, Fisher’s exact
test). CEA, carotid endarterectomy; CHS, cerebral hyper-
perfusion syndrome; ICH, intracerebral haemorrhage; sBP,
systolic blood pressure.
Post-carotid Endarterectomy Cerebral Hyperperfusion Syndrome 233and5,6,8,10,11,22,29e32 radiographic findings of cerebral
oedema.23,33 There were four reports of patients, who
had persisting hemiparesis despite rapid restoration of nor-
motension.6,23,29 Recent Cochrane reviews34,35 have found
a lack of robust evidence for dexamethasone or mannitol as
adjuncts in the treatment of ICH.
With treatment, 83% of patients with CHS made a good
recovery and 13% a partial recovery. One patient with CHS26
died; however, BP and treatment details are limited. Despite
treatment, the mortality of ICH was 51% (44/86), and 28%
were left with permanent disability23,36e40 (Table 1).
Discussion
A definition for post-CEA CHS is required as an end point for
future studies. We suggest the following four criteria should
be fulfilled:
(1) Within 30 days post-CEA;140 160 180 200 220
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Figure 3 Cumulative frequency of cerebral hyperperfusion
syndrome in relation to postoperative systolic blood pressure.
Above 150 mmHg systolic there is an inflexion point (nZ 16).
234 S. Bouri et al.(2) Evidence of hyperperfusion (on TCD, SPECT or CT/MR
perfusion imaging) OR sBP >180 mmHg (Fig. 3);
(3) Clinical features such as new headache, seizure, hem-
iparesis, Glasgow Coma Scale (GCS) < 15 OR radiolog-
ical features such as cerebral oedema or ICH; and
(4) No evidence of new cerebral ischaemia, postoperative
carotid occlusion and metabolic or pharmacologic cause.
BP thresholds
There are no published cases of CHS below a sBP of
135 mmHg. Fig. 3 demonstrates an inflexion point in the
cumulative incidence of CHS above a postoperative sBP of
150 mmHg. In Above a sBP of 180 mmHg, 81% of cases of
CHS had occurred. Studies showed reduced odds of ICH
when 140e160 mmHg or the preoperative sBP were used as
a target.1,4,24 These targets form the basis for the post-
operative BP control strategy in Fig. 4.Figure 4 Blood pressure control strategy for validation in a prosp
unit; CT, computed tomography; GCS, Glascow Coma Score; HDU
systolic blood pressure; TCD, transcranial Doppler.There was no evidence as to what numerical value BP
should be lowered to in establishedCHS,withmost successful
authors simply stating “normotension”. However, based on
Fig. 3, BP could be lowered to 140 mmHg sBP or higher if
symptoms resolve.
Choice of anti-hypertensive
The choice of ideal anti-hypertensive agent(s) is outside the
scope of this article. There are reports of crushed nifedi-
pine causing rapid uncontrolled hypotension,41,42 resulting
in end-organ ischaemia. It is also noteworthy that sodium
nitroprusside43 increases intracranial pressure and glyceryl
trinitrate can increase cerebral perfusion pressure and
augment headache.44 Guidelines are available for oral anti-
hypertensive therapy in the setting of stroke, which can be
modified by local consensus to select agent(s) with a short
onset of action.18,45ective study. CEA, carotid endarterectomy; CCU, coronary care
, high dependency unit; ICH, intracerebral haemorrhage; sBP,
Post-carotid Endarterectomy Cerebral Hyperperfusion Syndrome 235Duration of BP monitoring
With lengths of stay now as short as 24 h for CEA, a greater
proportion of CHS cases are expected to occur out of
hospital. It is important that patients be not discharged with
severe hypertension or an sBP that is rising. Patients with
labile BP should be considered for a home BP monitor for the
first postoperative week, after review by a physician. They
should return to the vascular unit if the sBP exceeds
160 mmHg, especially if they develop a new headache.
Cerebral perfusion measurements
Post-CEA, 12.5% of patients have a postoperative CBF
doubling, however we have found the incidence to be around
1%. Hence, relying on flow doubling to predict CHS is expec-
ted to have an appreciable false positive rate. In addition,
a handful of CHS cases occurred without a doubling of
CBF23,24 or MCAv.6 It was unclear whether due to deficient
autoregulation a lesser increase in CBF was enough to trigger
CHS or whether hyperperfusion was simply not present. Note
that poor bonewindows are reported in up to 10%,3,4 and TCD
or SPECT are not available in all centres.
New techniques such as MR and CT perfusion imaging
allow quantification of the perfusion differences between
cerebral hemispheres.23 These allow the clinician to rapidly
establish whether cerebral hyper- or hypoperfusion is
present in patients with new hemispheric symptoms and if
brain injury has occurred. In the case of new cerebral
infarction, hypertension may be required to maintain
perfusion to the ischaemic penumbra around an infarct.41
For institutions that do not have access to methods of
quantifying CBF, an sBP >180 mmHg is a useful surrogate,
as this is present in 81% of those with CHS.
Hypertension e causation or association?
Whether hypertension is a causal factor, a secondary
response to cerebral oedema or a chance association has
not yet been determined in a prospective cohort study;
however, the following observations are noted47:
(1) Cerebral perfusion pressure is directly related to mean
arterial pressure;
(2) Hypertension temporally preceded CHS in cases where
data were available;
(3) The incidence of severe hypertension was significantly
higher in CHS cases than in post-CEA controls (Fig. 2);
(4) The cumulative frequency of cases rose with post-
operative sBP (Fig. 3);
(5) Cerebral infarction was excluded before the diagnosis
of CHS was made; and
(6) CHS without ICH was reversible in most patients with
anti-hypertensive therapy.
Numerous authors4,5,8,22,48e53 have recommended metic-
ulous postoperative BP control based on level-3 evidence;
however, there are no cohort studies or randomised,
controlled trials in this area. BP targets vary widely,1,11,50,53
and only one unit has published a formal postoperative BP
control algorithm.53 From the results of this study,we suggesta BP control strategy for validation in a prospective study
(Fig. 4).
Limitations
There was heterogeneity in the definition of hypertension
and CHS. The BP at which ICH occurred was not mentioned
in all cases. Only 16 cases of CHS had postoperative BP
reported, and these were at different time points.
Conclusion
There is currently level-3 evidence for the prevention of
ICH through control of postoperative BP. From the available
data, we suggest a definition for CHS, BP thresholds,
duration of monitoring and a postoperative BP control
strategy for validation in a prospective study. The impli-
cations of this are that one in five patients would need
intravenous anti-hypertensives and home BP monitoring for
1 week.
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